How Menopause Affects Your Weight and Fat Distribution During the menopause transition, up to 70% of women gain weight
Recommendations include: 150-300 minutes weekly moderate-intensity aerobic activity Resistance training 2-3 times weekly to maintain muscle mass Non-exercise activity thermogenesis (NEAT) optimization through increased daily movement Pharmacological Alternatives: Beyond GLP-1 receptor agonists, FDA-approved weight loss medications include: Phentermine-topiramate (Qsymia): Appetite suppressant combination Naltrexone-bupropion (Contrave): Affects reward pathways and appetite Orlistat (Xenical, Alli): Lipase inhibitor reducing fat absorption These alternatives have different mechanisms, adverse effect profiles, and efficacy (typically 5-10% weight loss), allowing individualized selection
Metas Ad Library reveals Happy Mammoth currently has 3900 active ads being published across Facebook and Instagram
It has been hypothesised that GIPR agonism may moderate GLP-1-associated nausea, but this remains under investigation and should not be regarded as established
It is worth being honest about what this is and is not
Pharmacokinetics and safety profiles of beinaglutide injection, a Recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial